• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在同时表达VEGF和PROK1的结直肠癌中,预后较差(VEGF与PROK1之间无相关系数)。

The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).

作者信息

Goi Takanori, Nakazawa Toshiyuki, Hirono Yasuo, Yamaguchi Akio

机构信息

First Department of Surgery, University of Fukui, 9101193, Japan.

出版信息

Oncotarget. 2015 Oct 6;6(30):28790-9. doi: 10.18632/oncotarget.4744.

DOI:10.18632/oncotarget.4744
PMID:26318037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4745692/
Abstract

The angiogenic proteins vascular endothelial growth factor (VEGF) and prokineticin1 (PROK1) proteins are considered important in colorectal cancer, the relationship between their simultaneous expression and prognosis was investigated in the present study. VEGF and PROK1 expression in 620 primary human colorectal cancer lesions was confirmed via immunohistochemical staining with anti-VEGF and anti-PROK1 antibodies, and the correlation between the expression of these 2 proteins and recurrence/prognosis were investigated. VEGF protein was expressed in 329 (53.1%) and PROK1 protein was expressed in 223 (36.0%). PROK1 and VEGF were simultaneously expressed in 116 (18.7%) of the 620 cases. The correlation coefficient between VEGF expression and PROK1 expression was r = 0.11, and therefore correlation was not observed. Clinical pathology revealed that substantially lymphnode matastasis, hematogenous metastasis, or TMN advanced-stage IV was significantly more prevalent in cases that expressed both VEGF and PROK1 than in the cases negative for both proteins or those positive for only 1 of the proteins. Also the cases positive for both proteins exhibited the worst recurrence and prognosis. In the Cox proportional hazards model, VEGF and PROK1 expression was an independent prognostic factor. The prognosis was poorer in colorectal cancers that expressed both PROK1 and VEGF relative to the cases that expressed only 1 protein, and the expression of both proteins was found to be an independent prognostic factor.

摘要

血管生成蛋白血管内皮生长因子(VEGF)和促动力蛋白1(PROK1)被认为在结直肠癌中具有重要作用,本研究对它们的同时表达与预后之间的关系进行了调查。通过使用抗VEGF和抗PROK1抗体进行免疫组织化学染色,确认了620例原发性人类结直肠癌病变中VEGF和PROK1的表达,并研究了这两种蛋白表达与复发/预后之间的相关性。VEGF蛋白在329例(53.1%)中表达,PROK1蛋白在223例(36.0%)中表达。在620例病例中,116例(18.7%)同时表达PROK1和VEGF。VEGF表达与PROK1表达之间的相关系数为r = 0.11,因此未观察到相关性。临床病理显示,与两种蛋白均为阴性或仅一种蛋白为阳性的病例相比,同时表达VEGF和PROK1的病例中,实质性淋巴结转移、血行转移或TMN晚期IV期更为普遍。而且两种蛋白均为阳性的病例复发和预后最差。在Cox比例风险模型中,VEGF和PROK1表达是独立的预后因素。相对于仅表达一种蛋白的病例,同时表达PROK1和VEGF的结直肠癌预后较差,且发现两种蛋白的表达是独立的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da77/4745692/cf2e1059afdc/oncotarget-06-28790-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da77/4745692/faba95e76a6f/oncotarget-06-28790-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da77/4745692/cf2e1059afdc/oncotarget-06-28790-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da77/4745692/faba95e76a6f/oncotarget-06-28790-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da77/4745692/cf2e1059afdc/oncotarget-06-28790-g002.jpg

相似文献

1
The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).在同时表达VEGF和PROK1的结直肠癌中,预后较差(VEGF与PROK1之间无相关系数)。
Oncotarget. 2015 Oct 6;6(30):28790-9. doi: 10.18632/oncotarget.4744.
2
Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.促动力蛋白1蛋白表达是人类散发性结直肠癌一个有用的新预后因素。
Ann Surg Oncol. 2015 May;22(5):1496-503. doi: 10.1245/s10434-014-4150-3. Epub 2014 Oct 21.
3
The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer.在结直肠癌中同时靶向血管内皮生长因子(VEGF)和前动力蛋白1(PROK1)可增强抗肿瘤效果。
Oncotarget. 2015 Mar 20;6(8):6053-61. doi: 10.18632/oncotarget.3474.
4
Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancer.抗前动力蛋白1(PROK1)单克隆抗体抑制结直肠癌中的血管生成和肿瘤生长。
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S665-71. doi: 10.1245/s10434-014-3765-8. Epub 2014 May 17.
5
A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.一种基于三个基因的风险评分可预测切除的非小细胞肺癌的预后。
Int J Clin Exp Pathol. 2015 Dec 1;8(12):16081-8. eCollection 2015.
6
Prokineticin 1 expression in gastrointestinal tumors.胃腸道腫瘤中的促動力素 1 表達。
Anticancer Res. 2013 Dec;33(12):5311-5.
7
Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study.血浆促动力素 1 是结直肠癌根治性切除术后患者的预后生物标志物:一项回顾性队列研究。
World J Surg Oncol. 2021 Oct 18;19(1):302. doi: 10.1186/s12957-021-02421-0.
8
Correlation between Vascular Endothelial Growth Factor and Somatostatin Receptor with Progression and Prognosis in Gastric Cancer.血管内皮生长因子与生长抑素受体在胃癌进展及预后中的相关性
Hepatogastroenterology. 2014 Jun;61(132):1154-8.
9
Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) expression in colorectal cancer.内分泌腺源性血管内皮生长因子(EG-VEGF)在结直肠癌中的表达
J Surg Oncol. 2007 Dec 1;96(7):605-10. doi: 10.1002/jso.20716.
10
CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.细胞色素P450 24A1(CYP24A1)是人类结直肠癌进展和预后的潜在生物标志物。
Hum Pathol. 2016 Apr;50:101-8. doi: 10.1016/j.humpath.2015.11.008. Epub 2015 Nov 28.

引用本文的文献

1
Significance of CD70, VEGF, and CD90 Immunohistochemical Expression in Colorectal Cancer.CD70、VEGF 和 CD90 免疫组织化学表达在结直肠癌中的意义。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3691-3699. doi: 10.31557/APJCP.2024.25.10.3691.
2
Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate cancer.二硫键相关基因可作为潜在的预后生物标志物,提示前列腺癌的肿瘤微环境特征和免疫治疗反应。
Sci Rep. 2024 Jun 19;14(1):14107. doi: 10.1038/s41598-024-61679-y.
3
Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis.

本文引用的文献

1
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.日本结直肠癌学会(JSCCR)2014年结直肠癌治疗指南。
Int J Clin Oncol. 2015 Apr;20(2):207-39. doi: 10.1007/s10147-015-0801-z. Epub 2015 Mar 18.
2
Vascular endothelial growth factor a inhibition in gastric cancer.血管内皮生长因子a在胃癌中的抑制作用
Gastric Cancer. 2015 Jan;18(1):33-42. doi: 10.1007/s10120-014-0397-4. Epub 2014 Jul 4.
3
Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancer.
内分泌腺源性血管内皮生长因子/前动力蛋白-1在癌症发展和肿瘤血管生成中的作用
Int J Endocrinol. 2017;2017:3232905. doi: 10.1155/2017/3232905. Epub 2017 Mar 12.
4
Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.促动力蛋白受体2(PK-R2)的表达是人类结直肠癌的一个新的预后因素。
Oncotarget. 2015 Oct 13;6(31):31758-66. doi: 10.18632/oncotarget.5565.
抗前动力蛋白1(PROK1)单克隆抗体抑制结直肠癌中的血管生成和肿瘤生长。
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S665-71. doi: 10.1245/s10434-014-3765-8. Epub 2014 May 17.
4
Angiogenesis factors involved in the pathogenesis of colorectal cancer.参与结直肠癌发病机制的血管生成因子。
Curr Health Sci J. 2014 Jan;40(1):5-11. doi: 10.12865/CHSJ.40.01.01. Epub 2013 Dec 29.
5
Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer.上皮-间质转化与癌症干细胞表型:来自癌症生物学的见解及其对结直肠癌的治疗意义
Cancer Gene Ther. 2014 May;21(5):181-7. doi: 10.1038/cgt.2014.15. Epub 2014 May 2.
6
VEGF targets the tumour cell.VEGF 靶向肿瘤细胞。
Nat Rev Cancer. 2013 Dec;13(12):871-82. doi: 10.1038/nrc3627.
7
The VEGF pathway in lung cancer.血管内皮生长因子通路与肺癌。
Cancer Chemother Pharmacol. 2013 Dec;72(6):1169-81. doi: 10.1007/s00280-013-2298-3. Epub 2013 Oct 2.
8
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.癌症中血管生成和抗血管生成治疗的最新分子发现。
J Clin Invest. 2013 Aug;123(8):3190-200. doi: 10.1172/JCI70212. Epub 2013 Aug 1.
9
Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines.内分泌腺源性血管内皮生长因子通过亲代蛋白受体 2 增强结肠癌细胞系的细胞侵袭能力。
Oncol Rep. 2013 Feb;29(2):459-63. doi: 10.3892/or.2012.2124. Epub 2012 Nov 6.
10
Anti-angiogenesis therapy in cancer: current challenges and future perspectives.癌症的抗血管生成治疗:当前的挑战与未来展望。
Cancer Lett. 2012 Jul 28;320(2):130-7. doi: 10.1016/j.canlet.2012.03.008. Epub 2012 Mar 13.